|Articles|March 1, 2004
Refractive effect after CK stabilizes at 2 years
Editor's Note: The FDA's Ophthalmic Devices Panel last month voted unanimously to recommend approval of the Viewpoint CK System-used to perform the conductive keratoplasty procedure-for improvement of near vision in patients with emmetropic presbyopia (See Page 3, this issue). The data in this article were presented at a major ophthalmic meeting prior to the FDA's announcement.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT completes enrollment in 4FRONT-1, phase 3 trial of 4D-150 in AMD
2
Angiogenesis 2026: Continuous AI severity scoring could transform AMD monitoring
3
SparingVision completes PRODYGY trial patient dosing with SPVN06
4
Q&A: Optimizing the ocular surface for light adjustable lens technology
5
























